Glytec Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 79

Employees

  • Latest Deal Type
  • Series K

  • Latest Deal Amount
  • $10M

  • Investors
  • 2

Glytec General Information

Description

Developer of a cloud-based insulin management platform designed to improve diabetes care and insulin dosing in clinical settings. The company offers FDA-cleared, integrated software supported by patented technology and real-time decision support tools, enabling hospitals and healthcare providers to enhance patient safety, reduce readmissions, and streamline clinical workflows.

Contact Information

Website
glytec.com
Formerly Known As
Glucotec
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2300 Windy Ridge Parkway South East
  • Suite S-1125
  • Atlanta, GA 30339
  • United States
+1 (864)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Services
Corporate Office
  • 2300 Windy Ridge Parkway South East
  • Suite S-1125
  • Atlanta, GA 30339
  • United States
+1 (864)

Glytec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glytec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Later Stage VC (Series K) 25-Sep-2026 $10M Completed Generating Revenue
17. Later Stage VC 17-Jun-2025 Completed Generating Revenue
16. Debt - PPP 11-Aug-2023 Completed Generating Revenue
15. Later Stage VC 26-Apr-2021 Completed Generating Revenue
14. Later Stage VC (Series J) 29-May-2020 Completed Generating Revenue
13. Later Stage VC (Series I) 14-Oct-2019 Completed Generating Revenue
12. Later Stage VC (Series H) 07-Jun-2017 Completed Generating Revenue
11. Later Stage VC (Series G) 21-Mar-2016 Completed Generating Revenue
10. Later Stage VC (Series F) 20-Aug-2015 $5.1M $32M Completed Generating Revenue
9. Later Stage VC (Series E) 14-Aug-2014 $2.5M $26.9M Completed Generating Revenue
To view Glytec’s complete valuation and funding history, request access »

Glytec Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series J
Series I
Series H-1
Series H
Series G-1
Series G
Series F1
Series F
Series E 622,763 $0.001000 8% $7.4 $7.4 1x $6.91 0.14%
Series D 821,357 $0.001000 8% $6.73 $6.73 1x $6.44 0.18%
To view Glytec’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Glytec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cloud-based insulin management platform designed to improve diabetes care and insulin dosing in clinical
Enterprise Systems (Healthcare)
Atlanta, GA
79 As of 2025

Dallas, TX
 

Mountain View, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Glytec Competitors (14)

One of Glytec’s 14 competitors is Omada, a Formerly VC-backed company based in Dallas, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Omada Formerly VC-backed Dallas, TX
Lark Venture Capital-Backed Mountain View, CA
Canary Health Formerly VC-backed Los Angeles, CA
Health2Sync Venture Capital-Backed Taipei, Taiwan
Welldoc Venture Capital-Backed Columbia, MD
You’re viewing 5 of 14 competitors. Get the full list »

Glytec Patents

Glytec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023173129-A1 Advising diabetes treatments Inactive 11-Mar-2022
US-11481130-B2 Method, electronic device and computer program product for processing operation commands Active 31-Jul-2020
US-20220035527-A1 Method, electronic device and computer program product for processing operation commands Active 31-Jul-2020
US-12205698-B2 Advising diabetes medications Active 21-Dec-2017
US-20240170123-A1 Advising diabetes medications Active 21-Dec-2017 G16H20/13
To view Glytec’s complete patent history, request access »

Glytec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glytec Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hayfin Capital Management Asset Manager Minority
Savitr Capital Venture Capital Minority
To view Glytec’s complete investors history, request access »

Glytec FAQs

  • When was Glytec founded?

    Glytec was founded in 2006.

  • Where is Glytec headquartered?

    Glytec is headquartered in Atlanta, GA.

  • What is the size of Glytec?

    Glytec has 79 total employees.

  • What industry is Glytec in?

    Glytec’s primary industry is Enterprise Systems (Healthcare).

  • Is Glytec a private or public company?

    Glytec is a Private company.

  • What is Glytec’s current revenue?

    The current revenue for Glytec is .

  • How much funding has Glytec raised over time?

    Glytec has raised $127M.

  • Who are Glytec’s investors?

    Hayfin Capital Management and Savitr Capital have invested in Glytec.

  • Who are Glytec’s competitors?

    Omada, Lark, Canary Health, Health2Sync, and Welldoc are some of the 14 competitors of Glytec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process